BIOLOGIC MARKERS IN OCCUPATIONAL AND ENVIRONMENTAL MEDICINE By: Dr Chavoshi.

Slides:



Advertisements
Similar presentations
HYGIENE STANDARDS AND OCCUPATIONAL EXPOSURE LIMITS
Advertisements

Battlement Mesa Health Impact Assessment and Exposure/Health Study Stakeholders Meeting Roxana Witter, MD, MSPH John Adgate, PhD, MSPH Lee Newman, MD,
Genetic Susceptibility Can we identify cells, individuals or subpopulations that are genetically susceptible to radiation?
1 Aflatoxin exposure, health impacts, risk assessment and database Aflatoxin Stakeholders’ Workshop 3-4 December, 2012 Dar es Salaam, Tanzania.
Evaluation of a potential mutagenic MOA based on analysis of the weight of evidence and using the modified Hill criteria Martha M. Moore, Ph.D. Director,
Tumor Markers Lecture one By Dr. Reem Sallam. Objectives  To briefly introduce cancers, their incidence, some common terms, and staging system.  To.
Bio 130 Human Biology Cancer Normal cells have regulation that keeps their rates of cell division in check. Normal cells generally remain in one location.
Principles of Toxicology: The Study of Poisons
William H. Farland, Ph.D. Acting Deputy Assistant Administrator for Science Office of Research and Development U.S. ENVIRONMENTAL PROTECTION AGENCY Biomarkers:
Pathophysiology.
Biomonitoring ….a dialogue EnviroCancer Connections-LDL February 14, 2005 Discussion Leader: Suzanne Snedeker - BCERF.
Biomarkers and Risk Assessment for Chromium(VI) Qingshan Qu, MD (PI) Roy Shore, PhD (Co-I) Dept. of Environmental Med. NYU School of Medicine.
Design Elements: Primitives. Try to Make these Primitives.
University of Turku Department of Biochemistry Jukka-Pekka Suomela Biomarkers.
Environmental Health III. Epidemiology Shu-Chi Chang, Ph.D., P.E., P.A. Assistant Professor 1 and Division Chief 2 1 Department of Environmental Engineering.
Pharmacotherapy in the Elderly Judy Wong
Copyright 2002 Marc Rigas Issues in Exposure Assessment Marc L. Rigas, Ph.D. National Exposure Research Laboratory, U.S. Environmental Protection Agency.
What Do Toxicologists Do?
Biomonitoring II EnviroChem Connections Mini-Talk 1 on CDC’s 3rd Report Suzanne Snedeker Cornell University Sprecher Institute for Comparative Cancer Research.
Introduction of Cancer Molecular Epidemiology Zuo-Feng Zhang, MD, PhD University of California Los Angeles.
Health Effects of Radiation
Introduction to Molecular Epidemiology Jan Dorman, PhD University of Pittsburgh School of Nursing
Luděk Bláha, PřF MU, RECETOX BIOMARKERS AND TOXICITY MECHANISMS 13 – BIOMARKERS Summary and final notes.
Biomarkers Andrew McNaught BME. What is a biomarker? Gives us the ability to analyze organ function, diagnose diseases in a non-invasive way. Biomarkers.
Supercourse Environmental Exposure Assessment And Biomarkers Wael Al-Delaimy, MD, PhD.
Tumor Biomarkers are high lightened Once Again Cancer Facts Cancer etiology Tumor Genetics Tumor MarkersLocation Classification Uses methods of detection.
Environmental • failure analysis & prevention • health • technology development A leading engineering & scientific consulting firm dedicated to helping.
TRAINING FOR THE HEALTH SECTOR
Luděk Bláha, PřF MU, RECETOX BIOMARKERS AND TOXICITY MECHANISMS 11 – BIOMARKERS of EXPOSURE and SUSCEPTIBILITY.
TOXICOLOGY Trina Redford, Industrial Hygienist National Naval Medical Center Naval Business Bldg 615, 2 nd Fl. Philadelphia, PA.
Introduction of Department of Molecular Biology for Public Health in SCDC Ye Lu Shanghai Municipal Center for Disease Control & Prevention Shanghai Institute.
Luděk Bláha, PřF MU, RECETOX BIOMARKERS AND TOXICITY MECHANISMS 10 – BIOMARKERS Introduction.
New or increasing occupational exposure to chemical and biological agents Gérard Lasfargues Deputy Director General, Anses.
Cyanobacteria—Needs for Toxicology and Human Health Lorraine C. Backer National Center for Environmental Health Centers for Disease Control and Prevention.
Biomarkers Biomarkers - markers in biological systems with a sufficently long half-life which allow location where in the biological system change occur.
The science that deals with the recognition, evaluation and control of hazards in workplaces in order to prevent illness among employees. ?
MAIN TOXICITY TESTING. TESTING STRATEGIES A number of different types of data are used in order to establish the safety of chemical substances for use.
Pollution and Human Health
Dr Godfrey Grech University of Malta
Biological monitoring
!!!……Molecular Target Concept A gonist Antagonist.
Michael H. Dong MPH, DrPA, PhD  readings Epidemiology and Risk Assessment (4th of 10 Lectures on Toxicologic Epidemiology)
Francesca Sanna – 12/ Roma – IMEKOFOODS Water thermal pollution – Francesca Sanna – EMPIR Call 2016 Water thermal pollution metrology for biomarker.
TOXICOLOGY OCCUPATIONAL HAZARDS CHEMICAL PHYSICAL ERGONOMIC PSYCHOLOGIC BIOLOGIC.
Biologic Monitoring A. H. Mehrparvar, MD Occupational Medicine department Yazd University of Medical Sciences.
What is Cancer? A general term for a large group of diseases characterized by uncontrolled growth of abnormal cells.
Timing of exposure assessment in relation to exposure occurrence:  Historical or retrospective: i.e., exposure reconstruction; an attempt to identify.
PRINCIPLES OF TOXICOLOGY...a discussion of the fundamental means by which toxicological properties are determined.
NUATRC/TCEQ Air Toxics Workshop October Air Toxics Air Toxics: What We Know, What we Don’t Know, and What We Need to Know Human Health Effects –
Inflammatory Bowel Diseases November 19, 2007 NCDD Meeting Chair: Daniel K. Podolsky, MD Vice Chair: Eugene B. Chang, MD.
Part 1b Part 1b NATURE OF THE ENVIRONMENT AND POPULATIONS; BASIC CONCEPTS OF EXPOSURE, DOSE AND RISK.
Toxic effects Acute / chronic Reversible / irreversible Immediate / delayed Idiosyncratic - hypersensitivity Local / systemic Target organs.
An Introductory Lecture to Environmental Epidemiology Part 4. Some Issues in Exposure Assessment Mark S. Goldberg INRS-Institut Armand-Frappier, University.
Toxicogenomics Dr. M. Zdanowicz.
An Overview DCC Annual Retreat February 20, 2012.
Manganese Biomonitoring for assessment of Exposure to Airborne Manganese in Foundry Plants Dr. Seyedtaghi Mirmohammadi Assistant Professor. Indoor Air.
Students type their answers here
New research areas in personalised medicines
GENETIC BIOMARKERS.
Biologic Monitoring A. H. Mehrparvar, MD
HYGIENE STANDARDS AND OCCUPATIONAL EXPOSURE LIMITS
Chapter 1 Introduction to Biopharmaceutics & Pharmacokinetics
Genetic Susceptibility
The Genomics of Cancer and Molecular Testing:
Human Health and Disease
Biological monitoring
Jeopardy Final Jeopardy Unit 1- Unit 2- Unit 3- Unit 4- Lagniape $100
Health Effects of Radiation
Pollution and Human Health
Introduction to Risk Assessment
Presentation transcript:

BIOLOGIC MARKERS IN OCCUPATIONAL AND ENVIRONMENTAL MEDICINE By: Dr Chavoshi

Definition  Any substance, structure, or process that can be measured in the human body or human body products, that may influence or predict disease.

Types of Biomarkers  Biomarker of exposure or internal dose :( BLL, Cadmium in urine).  Biomarker of effects :( measurement of protein or DNA adducts).  Biomarker of susceptibility: demonstrate the possible differences between individuals in metabolism, immune responsiveness, DNA repair mechanisms or alterations of oncogenes and tumor and tumor suppressor genes activities.

Environmental vs biologic monitoring  Environmental monitoring measures the ambient exposure of a chemical through sampling of the air or surfaces at the workplace.  Acute exposures to chemicals, to evaluate engineering control measures, to prevent overexposure and to provide a more accurate monitoring of chemicals.

Selection of Biomarkers  Rout of exposure  Respiration rate  Metabolic and excretion rate  Genetic  Adipose tissue level

Biomarkers Exposure Internal dose Biologically effective dose Early biological effect Altered structure/ function Host factors(susceptibility) Clinical disease GenotypeEnvironment Biomarker ofBiomarker of susceptibility Early biological effect

Biomarker of exposure  Exposure measurement to chemical independent of rout of exposure.  Reflection of the amount of the chemical in question or its metabolite present in the biologic sample.  Direct measurement: urine, blood, exhaled air, feces, hair, nails, saliva, breast feeding  Examples: s-phenylmercapuric acid for benzen exposure, neutron activation for cadmium exposure

Characteristic of useful biomarkers of exposure  Correlation with exposure  Correlation with target tissue dose  Appearance is reversible  Influence of confounding and modifying factors is well characterized.  Suitable for application in the workplace

Biomarker of effect  Measure reversible biochemical changes that occure after receipt of an internal dose.  These markers may predict adverse effects.  They must be distinguished from tests that true pathological effects.  Examples: measurement of protein or DNA adduct burden for aromatic amine exposure.

Biomarker of susceptibility  Demonstrate the possible differences between individuals in metabolism, DNA repair, immune responsiveness, or alterations of oncogenes and tumor suppressor genes activities.  Measurement with using modern molecular biologic techniques, including the PCR, the polymorphisms, or genetic differences.  This type of biomarker is used for prevention of possible exposure risk.  Example: use of genetic testing for susceptibility to beryllium exposure.

Criteria for choosing and implementing a biomarker  Determinate must be present in an available biologic medium and suitable for sampling.  The sampling method must be convenient and acceptable to tested population.  The sampling method must produce representative and useful samples for analysis  Analysis method must be practical, accurate, and reproducible.  Responding to aberrant results.

Sampling  For accurate monitoring of exposures, the timing and appropriateness of sampling must be considered for each type of exposure.  Sampling during or at the end of a working shift for chemicals that are rapidly cleared from the body may require more immediate sampling.  Collection method may be important for accurate analysis  Selection of appropriate preservatives.  Baseline testing : For chemicals that accumulate in the body or for substantial inter individual variability. ( cadmium, lead, PCB).

Samples type  Blood: little variability between individuals and no need for correction for individual differences.  Urine: detection of various hydrophilic chemicals, metals, and metabolites.  A 24- hour urine collection is an accurate assessment  Urine sampling is not appropriate for advanced renal disease.  Exhaled air: useful for volatile chemicals, and no useful for aerosols, gases, vapors that decompose upon contact with body tissue or highly water soluble. Exhaled air sampling is not done in workers with emphysema.

Thanks for your attention